VaccinesStudies updated this monthAutism after vaccination — coincidence, or something people are not allowed to talk about openly?
What do Natural Therapy Specialists write?
Hubert Czerniak presents vaccination as the main cause of autism and compares diagnosis rates among the Amish and Americans.
Jerzy Jaśkowski calls the link between autism and vaccination indisputable and connects possible symptoms with mitochondrial dysfunction.
Jerzy Jaśkowski claims that children with congenital mitochondrial dysfunction may develop symptoms of autism after vaccination.
Piotr Witczak writes that learning about toxicology and nutrition changed how he viewed the rising number of autism diagnoses.
Piotr Witczak points out that both genetic susceptibility and environmental factors may affect the development of autism.
Piotr Witczak describes studies comparing autism with mercury poisoning and cites a conclusion that their symptoms are similar.
Piotr Witczak stresses that the link with MMR remains controversial, and that mercury need not be the only environmental factor.
Piotr Witczak considers mercury the dominant possible environmental cause of autism.
The STOP NOP Association reports that a court in Milan awarded compensation for autism said to have occurred after the Infanrix Hexa vaccine was given.
Jerzy Jaśkowski considers MMR the main cause of autism spectrum disorders and gives comparisons of diagnosis rates in different groups.
Jerzy Zięba claims that a US agency knew about a link between vaccination and autism, and that parents and doctors were deceived.
What does scientific research from PubMed · Europe PMC say?
We selected 9 studies with the best, positive results. This is a selection, not a full review of all research.
Total number of studies on this topic in PubMed: 893.
Aim of the study: There has been enormous debate regarding the possibility of a link between childhood vaccinations and the subsequent development of autism. This has in recent times become a major public health issue with vaccine preventable diseases increasing in the community due to the fear of a 'link' between vaccinations and autism.
Results: The cohort data revealed no relationship between vaccination and autism (OR: 0.99; 95% CI: 0.92 to 1.06) or ASD (OR: 0.91; 95% CI: 0.68 to 1.20), nor was there a relationship between autism and MMR (OR: 0.84; 95% CI: 0.70 to 1.01), or thimerosal (OR: 1.00; 95% CI: 0.77 to 1.31), or mercury (Hg) (OR: 1.00; 95% CI: 0.93 to 1.07). Similarly the case-control data found no evidence for increased risk of developing autism or ASD following MMR, Hg, or thimerosal exposure when grouped by condition (OR: 0.90, 95% CI: 0.83 to 0.98; p=0.02) or grouped by exposure type (OR: 0.85, 95% CI: 0.76 to 0.95; p=0.01). Findings of this meta-analysis suggest that vaccinations are not associated with the development of autism or autism spectrum disorder. Furthermore, the components of the vaccines (thimerosal or mercury) or multiple vaccines (MMR) are not associated with the development of autism or autism spectrum disorder.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Understanding the safety of vaccines is critical to inform decisions about vaccination. Our objective was to conduct a systematic review of the safety of vaccines recommended for children, adults, and pregnant women in the United States.
Results: Of 56,603 reviewed citations, 338 studies reported in 518 publications met inclusion criteria. For children, SoE was high for no increased risk of autism following measles, mumps, and rubella (MMR) vaccine. SoE was high for increased risk of febrile seizures with MMR. There was no evidence of increased risk of intussusception with rotavirus vaccine at the latest follow-up (moderate SoE), nor of diabetes (high SoE). There was no evidence of increased risk or insufficient evidence for key adverse events for newer vaccines such as 9-valent human papillomavirus and meningococcal B vaccines. For adults, there was no evidence of increased risk (varied SoE) or insufficient evidence for key adverse events for the new adjuvanted inactivated influenza vaccine and recombinant adjuvanted zoster vaccine. We found no evidence of increased risk (varied SoE) for key adverse events among pregnant women following tetanus, diphtheria, and acellular pertussis vaccine, including stillbirth (moderate SoE).
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: The hypothesized link between the measles, mumps, rubella (MMR) vaccine and autism continues to cause concern and challenge vaccine uptake. To evaluate whether the MMR vaccine increases the risk for autism in children, subgroups of children, or time periods after vaccination.
Results: During 5 025 754 person-years of follow-up, 6517 children were diagnosed with autism (incidence rate, 129.7 per 100 000 person-years). Comparing MMR-vaccinated with MMR-unvaccinated children yielded a fully adjusted autism hazard ratio of 0.93 (95% CI, 0.85 to 1.02). Similarly, no increased risk for autism after MMR vaccination was consistently observed in subgroups of children defined according to sibling history of autism, autism risk factors (based on a disease risk score) or other childhood vaccinations, or during specified time periods after vaccination. The study strongly supports that MMR vaccination does not increase the risk for autism, does not trigger autism in susceptible children, and is not associated with clustering of autism cases after vaccination. It adds to previous studies through significant additional statistical power and by addressing hypotheses of susceptible subgroups and clustering of cases.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: It has been suggested that vaccination against measles, mumps, and rubella (MMR) is a cause of autism.
Results: Of the 537,303 children in the cohort (representing 2,129,864 person-years), 440,655 (82.0 percent) had received the MMR vaccine. We identified 316 children with a diagnosis of autistic disorder and 422 with a diagnosis of other autistic-spectrum disorders. After adjustment for potential confounders, the relative risk of autistic disorder in the group of vaccinated children, as compared with the unvaccinated group, was 0.92 (95 percent confidence interval, 0.68 to 1.24), and the relative risk of another autistic-spectrum disorder was 0.83 (95 percent confidence interval, 0.65 to 1.07). There was no association between the age at the time of vaccination, the time since vaccination, or the date of vaccination and the development of autistic disorder. This study provides strong evidence against the hypothesis that MMR vaccination causes autism.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: We undertook an epidemiological study to investigate whether measles, mumps, and rubella (MMR) vaccine may be causally associated with autism.
Results: We identified 498 cases of autism (261 of core autism, 166 of atypical autism, and 71 of Asperger's syndrome). In 293 cases the diagnosis could be confirmed by the criteria of the International Classification of Diseases, tenth revision (ICD10: 214 [82%] core autism, 52 [31%] atypical autism, 27 [38%] Asperger's syndrome). There was a steady increase in cases by year of birth with no sudden "step-up" or change in the trend line after the introduction of MMR vaccination. There was no difference in age at diagnosis between the cases vaccinated before or after 18 months of age and those never vaccinated. There was no temporal association between onset of autism within 1 or 2 years after vaccination with MMR (relative incidence compared with control period 0.94 [95% CI 0.60-1.47] and 1.09 [0.79-1.52]). Developmental regression was not clustered in the months after vaccination (relative incidence within 2 months and 4 months after MMR vaccination 0.92 [0.38-2.21] and 1.00 [0.52-1.95]).
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: Concerns about potential associations between measles-mumps-rubella (MMR) vaccination and autism persist despite extensive prior research. Observational studies evaluating vaccine timing are susceptible to bias from healthcare utilization patterns, neurodevelopmental concerns and time-dependent exposure classification.
Results: In the primary 11.5-24 month landmark cohort, the first MMR vaccination was not associated with increased autism risk (aHR 0.97; 99% confidence interval 0.91-1.03). Across all age-specific landmark cohorts, aHRs remained near the null. The negative control analysis yielded a similarly near-null estimate (aHR 1.01; 99% confidence interval 0.99-1.04), supporting that residual bias is unlikely to explain the findings. In this large US cohort, age-anchored landmark analyses show no association between MMR vaccination before 24 months and childhood autism. The concordant near-null findings for both MMR and a negative control exposure support that the observed results are unlikely to be explained by residual confounding. These findings highlight the importance of age-specific analytic approaches in evaluating vaccine safety using observational data.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: This systematic review and meta-analysis examined vaccine hesitancy and related vaccination behaviours in autism spectrum disorder (ASD)-related populations. We aimed to quantify the burden of hesitancy and synthesize evidence on refusal, delay, and under-vaccination among caregivers of children with ASD and, where available, autistic adults.
Results: Twenty studies were included (16 quantitative, 3 qualitative, 1 mixed-methods). Among studies using a common instrument and threshold (PACV ≥ 50), the pooled prevalence of vaccine hesitancy among caregivers of children with ASD was 23.65% (95% CI 15.87-33.71). Compared with caregivers of neurotypical children, caregivers of children with ASD had higher odds of vaccine hesitancy or refusal (pooled OR = 2.31, 95% CI 1.66-3.22). They also had higher odds than families of children with other neurodevelopmental conditions (pooled OR = 2.23, 95% CI 1.48-3.35). Sibling-focused analyses suggested greater under-vaccination among younger siblings in ASD-affected families (pooled RR = 3.20, 95% CI 2.59-3.96). Narrative findings consistently implicated the disproven MMR-autism claim, safety concerns, and distrust. Vaccine hesitancy and related under-vaccination appear to be disproportionately concentrated in ASD-affected families.
“Not stated” does not mean nobody paid — the database does not always record it.
Results: Parental concerns about vaccines persist after a diagnosis of neurodevelopmental disorders. Tailored education and communication strategies are essential to support informed vaccine decision-making in these families and to prevent refusal for both diagnosed children and their siblings.
“Not stated” does not mean nobody paid — the database does not always record it.
Aim of the study: While vaccination has been hailed as one of the most significant, life-saving public health achievements, vaccine hesitancy and resistance has consistently come from those concerned about risks associated with vaccinating children. The Wakefield et al.
Results: Other key demographic factors that demonstrated significantly higher odds of selective MMR nonreceipt included income bracket greater than $50,000 and attending a private medical practice. The odds of both overall and selective MMR nonreceipt increased over time with no reduction observed after the retraction of the Wakefield et al. paper. Key demographic factors outlined herein provide an opportunity for targeted outreach to encourage increased MMR vaccination uptake.
“Not stated” does not mean nobody paid — the database does not always record it.
What do orthomolecular medicine doctors write?
Sources (18)
- Hubert Czerniak — Wyleczyć nieuleczalne – autyzm
- Jerzy Jaśkowski — Autyzm – czyli jak nas podstępnie uszkadzają i okradają
- Piotr Witczak — Jak zakończyć epidemię autyzmu? Autyzm związany nie tylko ze szczepionkami
- Piotr Witczak — Dlaczego rtęć należy uważać za główną przyczynę autyzmu?
- Stowarzyszenie STOP NOP — Szczepionka przyczyną autyzmu: prawomocny wyrok sądu niewygodny dla lobby farmaceutycznego – Ogólnopolskie Stowarzyszenie Wiedzy o Szczepieniach "STOP NOP"
- Jerzy Zięba — Szczepienia i Wakefield
- Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. · Vaccine 2014
- Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. · Vaccine 2021
- Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study. · Ann Intern Med 2019
- A population-based study of measles, mumps, and rubella vaccination and autism. · N Engl J Med 2002
- Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. · Lancet 1999
- Association Between First MMR Vaccination Before Age 2 Years and Childhood Autism in a U.S. EHR Cohort of 2.5 Million Children. · Pediatr Infect Dis J 2026
- Vaccine Hesitancy in Autism Spectrum Disorder: A Systematic Review With Meta-Analyses. · J Autism Dev Disord 2026
- Self-reported vaccine hesitancy and refusal among parents of children with autism spectrum disorder and other developmental delays: a cross-sectional study. · Eur J Pediatr 2026
- Trends in Selective Childhood Measles-Mumps-Rubella (MMR) Vaccine Nonreceipt Surrounding the MMR-Autism Controversy: National Immunization Survey Analyses, 1996-2019. · J Community Health 2026
- Orthomolecular Medicine News Service — Vaccine Science and Myth
- Orthomolecular Medicine News Service — Vitamins and Autism: The Real Story
- Orthomolecular Medicine News Service — The Dishonest Persecution of Andrew Wakefield: Over 50 scientific references say this important issue shall not be censored any longer
Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.